Washington State University · ChemistryNeuroNano Solutions
Anjali Sharma · Pullman, Washington
Research Focus
Dr. Anjali Sharma's lab at Washington State University focuses on creating innovative drug delivery systems for treating brain injuries and neurological disorders. The research aims to develop nanomedicine technologies that can cross the blood-brain barrier and selectively deliver therapeutic agents to neurons affected by injury. By leveraging a specialized nanoplatform, the lab seeks to enhance drug efficacy while minimizing side effects, which could significantly improve treatment outcomes.
drug deliverynanotechnologybrain injuriesneural targetingnanomedicine
Research Aims
3AIM 01Demonstrate the synthesis and uptake mechanisms of dendrimer-based drug conjugates.
AIM 02Assess the distribution, pharmacokinetics, and toxicity of the targeted nanotherapies.
AIM 03Evaluate the efficacy of the drug delivery system in a pediatric TBI mouse model.
Skills the Lab Values
nanoparticle synthesisin vivo imaginganimal modelspharmacokineticsfluorescence microscopy
Output against the department
Publications578top 14% of dept.30th of 216
this lab
most publishedleast published
Citations22ktop 22% of dept.48th of 216
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.